查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1996544

心臟瓣膜修復和置换装置市场：产品类型、组件、最终用户和销售管道划分－2026-2032年全球市场预测

Heart Valve Repair & Replacement Devices Market by Product Category, Component, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，心臟瓣膜修復和置换设备市场价值将达到 72 亿美元，到 2026 年将成长至 78 亿美元，到 2032 年将达到 127 亿美元，复合年增长率为 8.43%。

主要市场统计数据
基准年 2025 72亿美元
预计年份：2026年 78亿美元
预测年份 2032 127亿美元
复合年增长率 (%) 8.43%

全面概述了正在重塑心臟瓣膜修復和置换路径的临床、技术和商业性趋势的发展。

心臟瓣膜修復和置换领域正处于关键的转折点，传统外科手术与经导管技术的快速创新在此交汇融合。影像学、器材设计和手术全期管理的进步正在逐步改变临床决策流程，并为各个风险等级的患者拓展治疗选择。这项发展反映了心血管医学的更广泛变革，包括多学科心臟团队的建立、更精细的患者筛选标准，以及对长期瓣膜功能和患者生活品质的日益重视。

临床创新、影像技术的进步以及实证产品开发如何全面改变心臟瓣膜的治疗方法和护理途径。

近年来，我们不仅见证了器械的逐步改进，也见证了突破性变革，这些变革从根本上改变了临床医生治疗瓣膜疾病的方式。由于输送系统、密封机制和器械外形等方面的改进，微创经导管技术已从小众选择发展成为特定患者群体的主流治疗方法，从而减轻了手术负担并缩短了恢復时间。同时，外科人工瓣膜的进步，包括组织处理和血流动力学优化，也不断提升其在年轻和活跃患者中的应用效果。

本研究评估了近期关税变化如何影响整个心臟瓣膜设备生态系统的供应链、采购实务和策略製造决策。

关税环境的变化为整个心臟瓣膜器械生态系统的供应链设计、筹资策略和价格谈判带来了新的变数。关税调整正在影响进口零件和组装器械的成本结构，促使製造商重新评估筹资策略，并考虑近岸外包、供应商多元化或垂直整合以降低风险。这些应对措施正在影响前置作业时间、库存持有成本以及与医疗保健采购方的合约义务。

详细的細項分析揭示了手术和经导管装置路径、组织来源和修復方法如何定义临床和商业性差异。

将心臟瓣膜市场细分，可清楚展现影响产品开发和商业化策略的技术路径和临床决策树。在考虑置换疗法时，市场可分为外科手术和经导管两种方式。外科手术置换仍以机械瓣膜和生物瓣膜的选择为主要区别，而生物瓣膜可进一步细分为同种异体移植瓣膜、支架瓣膜和无支架瓣膜。支架瓣膜通常来自牛心包和猪组织。经导管置换则透过专用输送系统和针对特定解剖部位，进一步细分为多个领域。这包括经导管主动脉瓣置换术、经导管二尖瓣置换术和经导管肺动脉瓣置换术，每种系统都有其独特的器械设计限制和临床终点。

区域部署模式和进入趋势将决定监管、支付方和临床基础设施如何影响心臟瓣膜装置在全球市场的商业化。

地理因素在心臟瓣膜技术的部署模式、监管路径和商业模式中起着决定性作用。美洲拥有完善的介入治疗基础设施和活跃的临床试验活动，这有利于微创技术的快速普及和全面的上市后数据的收集。该地区的支付方在评估新器械时，越来越重视长期价值和疗效比较的证据。欧洲、中东和非洲（EMEA）地区的监管环境和报销机制各不相同，这两个地区的器械普及率都很高，且市场依赖集中采购，医院预算有限。在全部区域，定价策略和卫生技术评估（HTA）的结果对市场准入时间有显着的影响。

竞争与合作的动态动态，结合成熟的外科技术、敏捷的创新与策略伙伴关係，塑造了我们的市场领导地位。

心臟瓣膜领域的竞争格局呈现出两极化的态势：既有历史悠久的医疗器材巨头，也有专注于经导管和修復技术的敏捷创新者。成熟的医疗设备製造商在规模、监管专业知识和长期临床数据集方面拥有优势，这些优势能够支持其产品在医疗机构中的应用，而耐用性和可靠的性能仍然是关键考虑因素。这些企业通常利用涵盖组织处理、人工瓣膜工程和全球分销网络的综合产品组合，为临床教育和多市场推广提供支援。

透过整合证据产生、供应链弹性、临床医生培训和模组化技术设计，加速推广应用和商业性成功的实用建议。

领导者应优先考虑整合策略，将临床证据的获取与可扩展的商业营运和稳健的供应链结合。首先，投资于可靠的真实世界证据（RWE）项目，作为主要临床试验的补充，记录长期疗效、患者报告结局（PRO）以及在不同临床环境下的疗效比较。此类证据为与支付方对话奠定了基础，并有助于建立有利的报销途径。其次，透过多元化的供应商网路和区域生产能力，在製造和采购方面追求柔软性，降低关税和物流风险，同时保持品质和成本竞争力。

为了提供实际的见解，我们采用了一种高度透明的调查方法，结合了对临床医生的初步访谈、文献整合、医疗设备核准途径图绘製以及供应链风险评估。

本研究整合了透过对临床医生、医疗设备工程师、监管专家和采购经理进行结构化访谈收集的一手和二手证据，并辅以对同行评审的临床文献和手术註册资料的分析。一手研究着重于对手术决策、医疗设备选择标准和推广障碍的定性分析，而二手资讯则提供了关于技术趋势、监管先例和不断演变的临床指南的背景资讯。在调查方法方面，本研究优先采用多资讯来源检验，以确保每个主题结论的可靠性，并减少单一资讯来源观点所带来的偏差。

结论阐述了综合证据、营运韧性和策略商业化如何决定心臟瓣膜治疗领域的长期领导地位。

心臟瓣膜疾病的治疗和置换领域正迈入一个更为复杂的时代，器械创新、临床证据和系统层面的经济因素相互交织，共同决定哪些技术能够成功。随着经导管技术的扩展和外科人工瓣膜的不断发展，耐久性、再次干预途径及其与以患者为中心的治疗结果之间的相互作用，将日益影响治疗方法的选择。相关人员，将更有能力影响临床实践并获得长期价值。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：心臟瓣膜修復和置换器械市场（按产品类型）

  • 维修装置
    • 瓣环成形术
      • 手术环/带
      • 经导管环瓣环成形术
    • 球囊瓣环成形/瓣叶切开术
    • 索状韧带修復
    • 传单修復
    • 阀门周围洩漏的封闭
    • 经导管瓣膜边缘修復术（TEER）
      • 二尖瓣TER
      • 三尖瓣TEER
  • 更换阀门
    • 再手术解决方案
      • Valve-In-MAC
      • Valve-In-Ring
      • 阀中阀
    • 外科瓣膜置换术
      • 生物瓣膜
      • 附支架
      • 防锈的
      • 无需缝合/快速部署
      • 机械阀
    • 经导管瓣膜置换术
      • 主动脉瓣（TAVR）
      • 二尖瓣（TMVR）
      • 肺动脉瓣（TPVR）
      • 三尖瓣（TTVR）

第九章 心臟瓣膜修復与置换器械市场：依组件划分

  • 配件
    • 栓塞预防装置
    • 成像导管
    • 导入器/鞘套
    • 可转向导轨
  • 配送系统
  • 植入

第十章：心臟瓣膜修復与置换器械市场：依最终用户划分

  • 门诊手术中心
  • 心臟导管检查室
  • 医院
    • 区域医院/二级医疗机构
    • 三级和四级医疗中心
  • 专业心臟病中心

第十一章：心臟瓣膜修復与置换器械市场：依销售管道划分

  • 直销
  • 透过分销商销售
  • 集团采购组织
  • 在线/采购门户

第十二章 心臟瓣膜修復与置换器械市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：心臟瓣膜修復与置换器械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 心臟瓣膜修復和置换器械市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国心臟瓣膜修復与置换器械市场

第十六章：中国心臟瓣膜修復与置换器械市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Braile Biomedica
  • Corcym
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Peijia Medical Limited
  • Sahajanand Medical Technologies Limited
  • Terumo Corporation
  • TTK Healthcare Limited
  • Venus Medtech（Hangzhou）Inc.
Product Code: MRR-925E8149CC89

The Heart Valve Repair & Replacement Devices Market was valued at USD 7.20 billion in 2025 and is projected to grow to USD 7.80 billion in 2026, with a CAGR of 8.43%, reaching USD 12.70 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.20 billion
Estimated Year [2026] USD 7.80 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 8.43%

A comprehensive introduction to the evolving clinical, technological, and commercial dynamics reshaping heart valve repair and replacement pathways

The field of heart valve repair and replacement stands at a pivotal inflection point where surgical tradition intersects with rapid transcatheter innovation. Advances in imaging, device design, and perioperative management have progressively shifted clinical decision-making pathways, expanding therapeutic options for patients across risk spectra. This evolution reflects broader changes in cardiovascular care, including multidisciplinary heart teams, refined patient selection criteria, and a stronger emphasis on long-term valve performance and quality of life.

Clinicians and health systems now evaluate valve interventions not only through the lens of acute procedural success but also by durability, need for reintervention, and implications for future transcatheter access. As a result, technology developers and device manufacturers are prioritizing modularity, ease of deployment, and compatibility with valve-in-valve strategies. Concurrently, regulatory authorities and payers are increasingly focused on real-world evidence and comparative effectiveness, shaping the pathway for commercialization and reimbursement.

Taken together, these elements create a dynamic landscape in which clinical needs, technological capability, and commercial imperatives interact. Stakeholders that understand these dynamics and align product development, clinical evidence generation, and market access strategies will be best positioned to influence care pathways and capture opportunities arising from the shifting treatment paradigm.

How clinical innovation, imaging advances, and evidence-driven commercialization are collectively transforming heart valve treatment modalities and care pathways

Recent years have delivered transformative shifts that extend beyond incremental device improvements to alter how clinicians approach valve disease entirely. Minimally invasive transcatheter techniques have matured from niche options to mainstream therapies for certain patient groups, driven by improvements in delivery systems, sealing mechanisms, and device profiles that reduce procedural trauma and recovery time. At the same time, refinements in surgical prostheses, including tissue processing and hemodynamic optimization, continue to elevate performance for younger and more active patients.

Technology convergence has accelerated progress. Enhanced imaging modalities, computational modeling, and intra-procedural guidance systems now enable precision planning and device placement that reduce variability in outcomes. These tools foster higher confidence in treating complex anatomies, which expands the population eligible for less invasive approaches. Furthermore, the emphasis on valve durability and the management of reintervention pathways has intensified efforts to develop device platforms that support staged therapies, including valve-in-valve or hybrid approaches.

On the commercial front, strategic partnerships between device innovators and established clinical networks expedite the translation of new technologies into practice. Evidence generation strategies have evolved to include robust registries and pragmatic trials that capture longitudinal performance in routine care. Collectively, these shifts create a more competitive, evidence-driven environment where the ability to demonstrate clinical value, streamline adoption, and ensure long-term patient benefit determines success.

Assessing how recent tariff changes reshape supply chains, procurement behavior, and strategic manufacturing decisions across the heart valve device ecosystem

The tariff landscape has introduced new variables for supply chain design, procurement strategies, and pricing negotiations across the heart valve device ecosystem. Tariff adjustments influence cost structures for imported components and assembled devices, prompting manufacturers to reassess sourcing strategies and consider nearshoring, supplier diversification, or vertical integration to mitigate exposure. These responses have implications for lead times, inventory carrying costs, and contractual commitments with healthcare purchasers.

Clinician demand and hospital purchasing cycles respond to subtle shifts in total cost of ownership, particularly when tariff-induced price changes affect devices used routinely in high-volume centers. Hospitals and health systems may increase scrutiny of procurement decisions, demand clearer value propositions, and prioritize vendors that can demonstrate supply resilience and transparent pricing. In parallel, regulatory submissions and tender processes may require updated cost-effectiveness documentation that reflects changed input costs.

Beyond immediate procurement effects, tariffs can accelerate strategic consolidation among suppliers and trigger geographic repositioning of manufacturing capacity. For newer entrants, tariff volatility elevates the strategic importance of manufacturing flexibility and local clinical partnerships to support market entry. Meanwhile, established incumbents with diversified production footprints can leverage scale and logistics sophistication to maintain competitive advantage. Overall, tariff dynamics add a layer of operational complexity that requires proactive scenario planning and agile commercial execution.

Deep segmentation analysis revealing how surgical and transcatheter device pathways, tissue sourcing, and repair modalities define clinical and commercial differentiation

Segmenting the heart valve market illuminates distinct technology pathways and clinical decision trees that influence product development and commercialization strategies. When considering replacement therapies, the market divides into surgical and transcatheter approaches. Surgical replacement remains differentiated by mechanical and tissue valve options, with tissue valves further subdivided into homografts, stented and stentless designs; stented constructs commonly draw on bovine pericardial and porcine tissue sources. Transcatheter replacement introduces another axis of segmentation through dedicated delivery systems and anatomic targets, covering transcatheter aortic replacement, transcatheter mitral replacement, and transcatheter pulmonary replacement systems, each with unique device design constraints and clinical endpoints.

Repair therapies constitute a parallel but equally nuanced landscape. Surgical repair includes annuloplasty rings, chordal replacement devices, and valve reshaping technologies, where annuloplasty rings are themselves classified by flexibility characteristics into flexible, rigid, and semi-rigid designs, and chordal replacement options range from autologous pericardial reconstructions to synthetic chordae. The transcatheter repair domain has emerged with distinct system classes such as annuloplasty systems and leaflet approximation technologies like clip and alternative leaflet devices; within annuloplasty systems, commercially prominent approaches include band and loop-like solutions tailored to percutaneous anatomy.

Understanding these segmentation pathways clarifies clinical value propositions, regulatory evidence needs, and manufacturing implications. For example, tissue sourcing and processing impact durability narratives for surgical constructs, while delivery catheter design and anchoring strategies drive development priorities for transcatheter platforms. Similarly, the distinctions between repair and replacement inform reimbursement positioning and training requirements for implanting centers. Segment-aware strategies therefore enable developers and commercial teams to align R&D investments with procedural realities and payer expectations.

Regional adoption patterns and access dynamics that determine how regulatory, payer, and clinical infrastructures shape heart valve device commercialization across global markets

Geographic dynamics play a decisive role in adoption patterns, regulatory pathways, and commercial models for heart valve technologies. The Americas exhibit advanced interventional infrastructure and strong clinical trial activity, supporting rapid uptake of minimally invasive techniques and robust post-market data collection; payers in this region increasingly seek evidence of long-term value and comparative effectiveness when evaluating new devices. Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement landscape where high-adoption pockets coexist with markets that depend on centralized procurement and constrained hospital budgets; pricing strategies and health technology assessment outcomes strongly influence market access timelines across this region.

Asia-Pacific demonstrates diverse maturity across national health systems, with several markets showing rapid adoption driven by large patient populations and growing capacities in tertiary centers. In some countries within Asia-Pacific, local manufacturing and partnerships with regional clinical networks accelerate entry, while in others, regulatory harmonization and infrastructure build-out remain focal areas. Across all regions, differences in procedural volumes, clinician training pathways, and public versus private healthcare delivery models shape how technologies are introduced and scaled.

Regional insights underscore that a one-size-fits-all commercial approach will underdeliver. Instead, successful market strategies anticipate local regulatory requirements, adapt clinical evidence packages to regional payer expectations, and tailor training and service models to the operational realities of implanting centers. Cross-border partnerships, local clinical champions, and flexible supply models are instrumental in translating innovation into sustained regional adoption.

Competitive and collaborative dynamics that combine established surgical prowess with nimble innovation and strategic partnerships to shape market leadership

Competitive dynamics in the heart valve space reflect a mix of long-established surgical leaders and agile innovators focused on transcatheter and repair technologies. Incumbent surgical device manufacturers maintain strengths in scale, regulatory expertise, and long-term clinical datasets that underpin adoption in centers where durability and proven performance remain primary considerations. These organizations often leverage comprehensive portfolios that span tissue processing, prosthesis engineering, and global distribution networks to support clinical education and multi-market rollouts.

At the same time, smaller and more focused companies drive disruptive progress by concentrating on delivery systems, sealing technologies, and mechanisms that expand anatomical suitability for less invasive approaches. These firms frequently collaborate with academic centers to generate early clinical evidence and refine device iterations quickly through iterative learning. Strategic alliances and licensing agreements between innovators and larger firms are common as each side seeks complementary capabilities, whether in manufacturing scale, regulatory navigation, or market access execution.

Service and training ecosystems are also pivotal competitive assets. Providers who offer robust clinician training, simulation, and proctoring support accelerate procedural adoption and reduce variability in outcomes, thereby enhancing the commercial proposition. As adoption patterns shift, organizations that combine technical excellence with scalable clinician support and evidence generation capabilities will secure durable positions in clinical pathways.

Actionable recommendations that integrate evidence generation, supply chain resilience, clinician training, and modular technology design to accelerate adoption and commercial success

Leaders should prioritize integrated strategies that align clinical evidence generation with scalable commercial operations and resilient supply chains. First, invest in robust, real-world evidence programs that complement pivotal trials by documenting long-term performance, patient-reported outcomes, and comparative effectiveness in diverse clinical settings; such evidence underpins payer dialogues and supports favorable reimbursement pathways. Second, pursue manufacturing and sourcing flexibility through diversified supplier networks and regional production capacities to mitigate tariff and logistics risks while preserving quality and cost competitiveness.

Third, cultivate deep clinical partnerships and training infrastructure to accelerate safe adoption, reduce procedural variability, and foster local champions who can articulate device value within their networks. Fourth, design modular platforms and interoperable delivery systems that facilitate staged therapies and simplify inventory management for hospital systems; modularity also enhances the ability to iterate device lifecycles without disrupting established procedural workflows. Finally, adopt sophisticated pricing strategies that reflect total cost of care implications and support outcomes-based contracting where appropriate to address payer priorities and demonstrate value over time.

By executing on these interconnected priorities, industry leaders can convert technical advances into sustainable clinical adoption and commercial success while remaining responsive to evolving regulatory and payer environments.

Transparent research methodology combining primary clinician interviews, literature synthesis, device pathway mapping, and supply chain risk assessment to support actionable insights

This research synthesizes primary and secondary evidence gathered through structured interviews with clinicians, device engineers, regulatory specialists, and procurement leaders, supplemented by analysis of peer-reviewed clinical literature and procedural registries. Primary research emphasized qualitative insights into procedural decision-making, device selection criteria, and adoption barriers, while secondary sources provided context on technological trends, regulatory precedents, and clinical guideline evolution. The methodology prioritized triangulation across input types to ensure the robustness of thematic conclusions and to reduce bias associated with single-source perspectives.

Analytical approaches included device pathway mapping, clinical outcome triangulation, and supply chain risk assessment. Device pathway mapping linked design attributes to procedural workflows and training needs, whereas outcome triangulation compared early clinical reports with registry data to identify consistent performance signals. Supply chain assessments evaluated sourcing concentration, logistics dependencies, and potential tariff impacts on cost and lead time. Wherever possible, findings were validated through follow-up discussions with domain experts to refine interpretation and test scenario plausibility.

The resulting synthesis focuses on actionable implications rather than predictive estimates, enabling stakeholders to apply insights directly to strategic planning, product development prioritization, and market entry sequencing. Transparency in methods supports reproducibility and allows clients to request deeper dives into specific segments or geographies as needed.

Concluding perspective on how integrated evidence, operational resilience, and strategic commercialization will define long-term leadership in heart valve therapies

The heart valve repair and replacement domain is transitioning to a more nuanced era where device innovation, clinical evidence, and system-level economics jointly determine which technologies succeed. As transcatheter techniques expand and surgical prostheses continue to evolve, the interplay between durability, reintervention pathways, and patient-centered outcomes will increasingly drive therapeutic choices. Stakeholders who integrate rigorous evidence generation with agile manufacturing and targeted regional strategies will be best positioned to influence clinical practice and capture long-term value.

Operational resilience and deliberate commercialization approaches matter now more than ever. Tariff dynamics and supply chain complexities require proactive planning, while competitive differentiation depends on demonstrating real-world benefits that resonate with clinicians, payers, and health system leaders. Companies that invest in clinician training, scalable service models, and modular device platforms will reduce barriers to adoption and support broader procedural diffusion.

Ultimately, sustained leadership in this space will come from organizations that balance scientific rigor with commercial pragmatism, anchoring product strategies in demonstrable patient benefit while ensuring that logistical and economic considerations support reliable, affordable access to care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Valve Repair & Replacement Devices Market, by Product Category

  • 8.1. Repair Devices
    • 8.1.1. Annuloplasty
      • 8.1.1.1. Surgical Rings/Bands
      • 8.1.1.2. Transcatheter Annuloplasty
    • 8.1.2. Balloon Valvuloplasty/Commissurotomy
    • 8.1.3. Chordal Repair
    • 8.1.4. Leaflet Repair
    • 8.1.5. Paravalvular Leak Closure
    • 8.1.6. Transcatheter Edge-To-Edge Repair (TEER)
      • 8.1.6.1. Mitral TEER
      • 8.1.6.2. Tricuspid TEER
  • 8.2. Replacement Valves
    • 8.2.1. Redo Solutions
      • 8.2.1.1. Valve-In-MAC
      • 8.2.1.2. Valve-In-Ring
      • 8.2.1.3. Valve-In-Valve
    • 8.2.2. Surgical Valve Replacement
      • 8.2.2.1. Bioprosthetic Valves
      • 8.2.2.1.1. Stented
      • 8.2.2.1.2. Stentless
      • 8.2.2.1.3. Sutureless/Rapid-Deployment
      • 8.2.2.2. Mechanical Valves
    • 8.2.3. Transcatheter Valve Replacement
      • 8.2.3.1. Aortic (TAVR)
      • 8.2.3.2. Mitral (TMVR)
      • 8.2.3.3. Pulmonary (TPVR)
      • 8.2.3.4. Tricuspid (TTVR)

9. Heart Valve Repair & Replacement Devices Market, by Component

  • 9.1. Accessories
    • 9.1.1. Embolic Protection Devices
    • 9.1.2. Imaging Catheters
    • 9.1.3. Introducers/Sheaths
    • 9.1.4. Steerable Guides
  • 9.2. Delivery System
  • 9.3. Implant

10. Heart Valve Repair & Replacement Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Catheterization Labs
  • 10.3. Hospitals
    • 10.3.1. Community/Secondary Hospitals
    • 10.3.2. Tertiary/Quaternary Centers
  • 10.4. Specialty Heart Centers

11. Heart Valve Repair & Replacement Devices Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
  • 11.3. Group Purchasing Organization
  • 11.4. Online/Procurement Portals

12. Heart Valve Repair & Replacement Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Heart Valve Repair & Replacement Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Heart Valve Repair & Replacement Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Heart Valve Repair & Replacement Devices Market

16. China Heart Valve Repair & Replacement Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Boston Scientific Corporation
  • 17.7. Braile Biomedica
  • 17.8. Corcym
  • 17.9. CryoLife, Inc.
  • 17.10. Edwards Lifesciences Corporation
  • 17.11. JenaValve Technology, Inc.
  • 17.12. Lepu Medical Technology (Beijing) Co., Ltd.
  • 17.13. LivaNova PLC
  • 17.14. Medtronic plc
  • 17.15. Meril Life Sciences Pvt. Ltd.
  • 17.16. MicroPort Scientific Corporation
  • 17.17. Peijia Medical Limited
  • 17.18. Sahajanand Medical Technologies Limited
  • 17.19. Terumo Corporation
  • 17.20. TTK Healthcare Limited
  • 17.21. Venus Medtech (Hangzhou) Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL RINGS/BANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL RINGS/BANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL RINGS/BANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER ANNULOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER ANNULOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER ANNULOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BALLOON VALVULOPLASTY/COMMISSUROTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BALLOON VALVULOPLASTY/COMMISSUROTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BALLOON VALVULOPLASTY/COMMISSUROTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY LEAFLET REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY LEAFLET REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY LEAFLET REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PARAVALVULAR LEAK CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PARAVALVULAR LEAK CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PARAVALVULAR LEAK CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL TEER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL TEER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL TEER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID TEER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID TEER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID TEER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-MAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-MAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-MAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUTURELESS/RAPID-DEPLOYMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUTURELESS/RAPID-DEPLOYMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUTURELESS/RAPID-DEPLOYMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AORTIC (TAVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AORTIC (TAVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AORTIC (TAVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL (TMVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL (TMVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL (TMVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PULMONARY (TPVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PULMONARY (TPVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PULMONARY (TPVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID (TTVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID (TTVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID (TTVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMAGING CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMAGING CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMAGING CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY INTRODUCERS/SHEATHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY INTRODUCERS/SHEATHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY INTRODUCERS/SHEATHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STEERABLE GUIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STEERABLE GUIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STEERABLE GUIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMMUNITY/SECONDARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMMUNITY/SECONDARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMMUNITY/SECONDARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TERTIARY/QUATERNARY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TERTIARY/QUATERNARY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TERTIARY/QUATERNARY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY HEART CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY HEART CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY HEART CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP PURCHASING ORGANIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP PURCHASING ORGANIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP PURCHASING ORGANIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ONLINE/PROCUREMENT PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ONLINE/PROCUREMENT PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ONLINE/PROCUREMENT PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)

TA